| Patent application number | Description | Published |
|---|
| 20110185129 | SECONDARY JAVA HEAPS IN SHARED MEMORY - A computing system includes a first virtual machine associated with a memory region readable by the first virtual machine, and a first private memory region. A data object is created by the first virtual machine in the sharable memory region, readable and writeable by the first virtual machine and a second virtual machine. A mapping is established between the first virtual machine and a particular area of the shareable memory region. The computing system includes the second virtual machine associated with a second private memory region, and a reference to the particular area of the shareable memory region. The mapping enables both the first virtual machine and second virtual machine to read and write second data in the shareable memory region without creating a copy of the second data in the first and second private memory regions. | 07-28-2011 |
| 20110258333 | CLOUD CONNECTOR KEY - A cloud connector key includes a network interface configured to connect to a network, a mass storage interface configured to connect to a network isolated device, and a computation module operatively connected to the network interface and the mass storage interface. The computational module is configured to connect to a cloud repository using the network interface by obtaining, from storage on the cloud connector key, a network address of the cloud repository, requesting connection to the cloud repository using the network address, and authenticating, using credentials in the storage on the cloud connector key, to an account in the cloud repository. The computational module is further configured to transfer a file between the account in the cloud repository and a network isolated device via the mass storage interface. | 10-20-2011 |
| Patent application number | Description | Published |
|---|
| 20100215772 | AMINOPYRIMIDINES USEFUL AS KINASE INHIBITORS - The present invention relates to compounds useful as inhibitors of Aurora protein kinases. The invention also provides pharmaceutically acceptable compositions comprising those compounds and methods of using the compounds and compositions in the treatment of various disease, conditions, and disorders. The invention also provides processes for preparing compounds of the invention. | 08-26-2010 |
| 20110046104 | AMINOPYRIMIDINES USEFUL AS KINASE INHIBITORS - The present invention relates to compounds useful as inhibitors of Aurora protein kinases. The invention also provides pharmaceutically acceptable compositions comprising those compounds and methods of using the compounds and compositions in the treatment of various disease, conditions, and disorders. The invention also provides processes for preparing compounds of the invention. | 02-24-2011 |
| 20110060013 | THIAZOLES AND PYRAZOLES USEFUL AS KINASE INHIBITORS - The present invention relates to compounds useful as inhibitors of Aurora protein kinases. The invention also provides pharmaceutically acceptable compositions comprising those compounds and methods of using the compounds and compositions in the treatment of various disease, conditions, and disorders. The invention also provides processes for preparing compounds of the invention. | 03-10-2011 |
| 20110269732 | DRUG DISCOVERY METHODS - The present invention relates to drug discovery methods, particularly methods for assaying compounds for activity as Aurora kinase inhibitors. This invention also relates to a pharmacophore describing compounds that are able to promote a conformational change in the protein AuroraB and whose binding constant for the two-step process is given as Ki*. Finally, this invention also relates to compounds having the features of the pharmacophore. | 11-03-2011 |
